Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Qualcomm has acquired the generative AI division of VinAI, an AI research company headquartered in Hanoi, for an undisclosed ...
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Explore more
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...
Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results